ACKR1 and influenza: More recently, PEI was shown to exhibit robust mucosal adjuvanticity and protective immunity against influenza and herpes simplex virus-2 when administered intranasally with hemagglutinin or glycoprotein D antigens co-formulated with PEI [65].